2m 2m 2m 2m 2m 2m 2m
PTC Therapeutics (PTCT)
NASDAQ
$80.75-$0.58 (-0.71%)
Price as of Jul 13, 2026 6:18 PM EDT- $7.0BMarket Cap
- 64.44%1-Year Change
- BiotechnologyIndustry
PTC Therapeutics (PTCT)
$80.75-$0.58 (-0.71%)
PTCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $81.33 | ||
Change | -$3.52 (-4.15%) | ||
Open | $83.24 | ||
High | $83.67 | ||
Low | $80.69 | ||
Previous Close | $84.85 | ||
Volume | 985,956 | ||
30-Day Average Volume | 2,874,259 | ||
1-Week Change | -4.81% | ||
1-Month Change | 8.24% | ||
1-Year Change | 64.44% | ||
3-Year Change | 104.24% | ||
5-Year Change | 87.31% | ||
Fundamentals | |||
Shares Outstanding | 82.9M | ||
Total Assets | $2.9B | ||
Market Cap | $7.0B | ||
Enterprise Value | $6.8B | ||
Period: QTR TTM FY | |||
Revenue | $225.6M | ||
Net Income | -$2.8M | ||
Free Cash Flow | -$60.2M | ||
EBIT | $46.6M | ||
EBITDA | $62.0M | ||
Net Working Capital | $1.3B | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | 109 | ||
Enterprise Value/Revenue | 30 | ||
P/B | -39 | ||
P/E | -2,828 | ||
PEG | -29 | ||
Price/Free Cash Flow | -117 | ||
Price/Operating Cash Flow | -119 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue